D. Evstratov

Recurrent deep vein thrombosis in children with malignant blood diseases: literature review

P. Zharkov, D. Morozova, D. Evstratov, 2019, Oncohematology.

Results of multicenter international trail for pediatric primary mediastinal B-cell lymphoma treated according to protocols B-NHL-M-10 and DA-EPOCH-R

Y. Likar, N. Miakova, E. Samochatova, 2019, Pediatric Hematology/Oncology and Immunopathology.

Deep veins thrombosis in children with blood diseases

P. Zharkov, G. Novichkova, D. Morozova, 2019, Oncohematology.

Brentuximab vedotin in the treatment of a patient with refractory Hodgkin disease and Proteus syndrome – a case report and discussion

Y. Skvortsova, N. Myakova, A. Maschan, 2015, Clinical case reports.

The first experience of using MEK inhibitors for type 1 neurofibromatosis in children in the Russian Federation in a hospital for short-term treatment at the National Medical Research Center

G. Ovsyannikova, L. Papusha, M. Kurnikova, 2021 .

Efficacy and safety of direct oral anticoagulants in children in real clinical practice

D. B. Florinskiy, P. Zharkov, D. Fedorova, 2023, Russian Journal of Pediatric Hematology and Oncology.

The THROMB-HEM study: first results and future prospects

P. Zharkov, G. Novichkova, D. Fedorova, 2022, Pediatric Hematology/Oncology and Immunopathology.

The role of blinatumomab in the treatment of B-cell relapses of acute lymphoblastic leukemia in children: own experience

N. Myakova, L. Shelikhova, A. Popov, 2023, Pediatric Hematology/Oncology and Immunopathology.

The use of inotuzumab ozogamicin in children with relapsed/refractory B-lineage acute lymphoblastic leukemia

N. Myakova, G. Novichkova, L. Shelikhova, 2023, Pediatric Hematology/Oncology and Immunopathology.